Obtenga las últimas noticias sobre las acciones de Eagle Pharmaceuticals con actualizaciones sobre las tendencias del mercado, las finanzas y el análisis de Benzinga. Manténgase informado sobre el rendimiento de EGRX

Últimas noticias sobre

Eagle Pharmaceuticals

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.

EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals Inc

Markets

Press Releases

Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration

Eagle Pharmaceuticals Announces Amendment to Limited Duration Stockholder Rights Plan

News

Financing

Contracts

Eagle Pharmaceuticals Announces $69 Million Agreement to Monetize BENDEKA® Royalties

Eagle Pharmaceuticals Announces 2025 Annual Meeting Date

Management

Eagle Pharmaceuticals to Appoint Abhinav Jain to its Board of Directors

Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years

Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements

Earnings

Eagle Pharmaceuticals Announces Availability of Unaudited Second Quarter 2025 Financial Statements

Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders

Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan

EGRX

Piper Sandler

Comments

Eagle Pharmaceuticals Noticias bursátiles

Noticias

Últimas noticias sobre

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL